Skip to main content

Congestive Heart Failure News (Page 5)

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the Furoscix Indication in Heart Failure

Furoscix is now indicated for the treatment of congestion due to fluid overload in adult patients with chronic heart failure, regardless of New York Heart Association (NYHA) functional class...

FDA Approves Entresto (sacubitril/valsartan) for Heart Failure

July 7, 2015 – The U.S. Food and Drug Administration today approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. The drug has been shown to reduce the rate of...

FDA Medwatch Alert: Dobutamine Injection (250mg/20mL)/Hospira: Recall - Visible Particulates

ISSUE: Hospira, Inc. issued a nationwide recall to the user level for one lot of Dobutamine Injection, USP, 250 mg, 20 mL, Single-dose fliptop vial, (NDC 0409-2344-02), Lot 27-352-DK. (NDC and lot...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Left Ventricular Dysfunction, Cardiovascular Conditions and Disorders

Related drug support groups

lisinopril, metoprolol, warfarin, spironolactone, Coumadin, triamcinolone, carvedilol, Metoprolol Succinate ER, diltiazem, view more... Lasix, furosemide, Entresto, bisoprolol, valsartan, Jardiance, ramipril, Farxiga, digoxin, prazosin, nitroglycerin, Diovan, Coreg